148 related articles for article (PubMed ID: 38394388)
1. Brusatol's anticancer activity and its molecular mechanism: a research update.
Xi W; Zhao C; Wu Z; Ye T; Zhao R; Jiang X; Ling S
J Pharm Pharmacol; 2024 Feb; ():. PubMed ID: 38394388
[TBL] [Abstract][Full Text] [Related]
2. Brusatol: A potential sensitizing agent for cancer therapy from Brucea javanica.
He T; Zhou F; Su A; Zhang Y; Xing Z; Mi L; Li Z; Wu W
Biomed Pharmacother; 2023 Feb; 158():114134. PubMed ID: 36525821
[TBL] [Abstract][Full Text] [Related]
3. Research progress of matrine's anticancer activity and its molecular mechanism.
Chen F; Pan Y; Xu J; Liu B; Song H
J Ethnopharmacol; 2022 Mar; 286():114914. PubMed ID: 34919987
[TBL] [Abstract][Full Text] [Related]
4. Brusatol: A potential anti-tumor quassinoid from
Yu XQ; Shang XY; Huang XX; Yao GD; Song SJ
Chin Herb Med; 2020 Oct; 12(4):359-366. PubMed ID: 36120179
[TBL] [Abstract][Full Text] [Related]
5. The anti-hepatocellular carcinoma effect of Brucea javanica oil in ascitic tumor-bearing mice: The detection of brusatol and its role.
Wang T; Dou Y; Lin G; Li Q; Nie J; Chen B; Xie J; Su Z; Zeng H; Chen J; Xie Y
Biomed Pharmacother; 2021 Feb; 134():111122. PubMed ID: 33341052
[TBL] [Abstract][Full Text] [Related]
6. Brusatol, an NRF2 inhibitor for future cancer therapeutic.
Cai SJ; Liu Y; Han S; Yang C
Cell Biosci; 2019; 9():45. PubMed ID: 31183074
[TBL] [Abstract][Full Text] [Related]
7. Nrf2 Inhibitor, Brusatol in Combination with Trastuzumab Exerts Synergistic Antitumor Activity in HER2-Positive Cancers by Inhibiting Nrf2/HO-1 and HER2-AKT/ERK1/2 Pathways.
Yang Y; Tian Z; Guo R; Ren F
Oxid Med Cell Longev; 2020; 2020():9867595. PubMed ID: 32765809
[TBL] [Abstract][Full Text] [Related]
8. Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2.
Olayanju A; Copple IM; Bryan HK; Edge GT; Sison RL; Wong MW; Lai ZQ; Lin ZX; Dunn K; Sanderson CM; Alghanem AF; Cross MJ; Ellis EC; Ingelman-Sundberg M; Malik HZ; Kitteringham NR; Goldring CE; Park BK
Free Radic Biol Med; 2015 Jan; 78():202-12. PubMed ID: 25445704
[TBL] [Abstract][Full Text] [Related]
9. Brucea javanica: A review on anticancer of its pharmacological properties and clinical researches.
Li KW; Liang YY; Wang Q; Li Y; Zhou SJ; Wei HC; Zhou CZ; Wan XH
Phytomedicine; 2021 Jun; 86():153560. PubMed ID: 33858739
[TBL] [Abstract][Full Text] [Related]
10. Brusatol isolated from Brucea javanica (L.) Merr. induces apoptotic death of insect cell lines.
Zhang L; Feng X; Ma D; Yang J; Jiang H; Zhang Y; He W
Pestic Biochem Physiol; 2013 Sep; 107(1):18-24. PubMed ID: 25149230
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive anti-tumor effect of Brusatol through inhibition of cell viability and promotion of apoptosis caused by autophagy via the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.
Ye R; Dai N; He Q; Guo P; Xiang Y; Zhang Q; Hong Z; Zhang Q
Biomed Pharmacother; 2018 Sep; 105():962-973. PubMed ID: 30021391
[TBL] [Abstract][Full Text] [Related]
12. Brusatol Enhances the Radiosensitivity of A549 Cells by Promoting ROS Production and Enhancing DNA Damage.
Sun X; Wang Q; Wang Y; Du L; Xu C; Liu Q
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347930
[TBL] [Abstract][Full Text] [Related]
13. Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway.
Guo S; Zhang J; Wei C; Lu Z; Cai R; Pan D; Zhang H; Liang B; Zhang Z
Cancer Chemother Pharmacol; 2020 Jun; 85(6):1097-1108. PubMed ID: 32449143
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic activities of brusatol in human non-small cell lung cancer cells: Involvement of ROS-mediated mitochondrial-dependent pathway and inhibition of Nrf2-mediated antioxidant response.
Xie J; Lai Z; Zheng X; Liao H; Xian Y; Li Q; Wu J; Ip S; Xie Y; Chen J; Su Z; Lin Z; Yang X
Toxicology; 2021 Mar; 451():152680. PubMed ID: 33465425
[TBL] [Abstract][Full Text] [Related]
15. Brusatol overcomes chemoresistance through inhibition of protein translation.
Harder B; Tian W; La Clair JJ; Tan AC; Ooi A; Chapman E; Zhang DD
Mol Carcinog; 2017 May; 56(5):1493-1500. PubMed ID: 28019675
[TBL] [Abstract][Full Text] [Related]
16. Anticancer effects and mechanisms of astragaloside‑IV (Review).
Zhou L; Li M; Chai Z; Zhang J; Cao K; Deng L; Liu Y; Jiao C; Zou GM; Wu J; Han F
Oncol Rep; 2023 Jan; 49(1):. PubMed ID: 36367181
[No Abstract] [Full Text] [Related]
17. Pharmacokinetic, metabolic profiling and elimination of brusatol in rats.
Guo N; Xu X; Yuan G; Chen X; Wen Q; Guo R
Biomed Chromatogr; 2018 Dec; 32(12):e4358. PubMed ID: 30089336
[TBL] [Abstract][Full Text] [Related]
18. In vitro antitrypanosomal activities of quassinoid compounds from the fruits of a medicinal plant, Brucea javanica.
Bawm S; Matsuura H; Elkhateeb A; Nabeta K; Subeki ; Nonaka N; Oku Y; Katakura K
Vet Parasitol; 2008 Dec; 158(4):288-94. PubMed ID: 18986767
[TBL] [Abstract][Full Text] [Related]
19. Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism.
Ren D; Villeneuve NF; Jiang T; Wu T; Lau A; Toppin HA; Zhang DD
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1433-8. PubMed ID: 21205897
[TBL] [Abstract][Full Text] [Related]
20. Brusatol inhibits the growth of renal cell carcinoma by regulating the PTEN/PI3K/AKT pathway.
Wang T; Chen Z; Chen H; Yu X; Wang L; Liu X
J Ethnopharmacol; 2022 Apr; 288():115020. PubMed ID: 35066068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
